New Pancreatic Cancer Drug Reaches California Patient

A San Clemente man became one of the first patients in America to receive daraxonrasib, a groundbreaking drug targeting a mutation found in 90% of pancreatic cancers.

After months of declining health, Peter Thomas got the call that changed everything.